Cronos (CRON) Net Income towards Common Stockholders (2019 - 2026)
Cronos (CRON) posted quarterly Net Income towards Common Stockholders of $15.7 million for Q1 2026, up 103.43% year-over-year from $7.7 million in Q1 2025, and up 3299.8% quarter-over-quarter from -$491000.0 in Q4 2025.
Cronos (CRON) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Cronos' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 103.43% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $5.1 million (down 34.49% YoY), while the FY2023 annual figure was -$4.1 million, up 69.65% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $15.7 million, up from -$491000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $28.3 million in Q3 2025, with the low at -$38.5 million in Q2 2025.
- The 4-year median for Net Income towards Common Stockholders is -$856500.0 (2023), against an average of -$50000.0.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 4710.98% in 2022, then surged 104.63% in 2023.
- Cronos' Net Income towards Common Stockholders stood at -$2.7 million in 2022, then jumped by 104.63% to $124000.0 in 2023, then tumbled by 495.97% to -$491000.0 in 2025, then jumped by 3299.8% to $15.7 million in 2026.
- Business Quant data shows CRON's Net Income towards Common Stockholders at $15.7 million in Q1 2026, -$491000.0 in Q4 2025, and $28.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 710.19 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 35.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.66 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -491,000.00 |
| Sep 30, 2025 | 28.32 Mn |
| Jun 30, 2025 | -38.48 Mn |
| Mar 31, 2025 | 7.72 Mn |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | -182,000.00 |
| Jun 30, 2023 | -2.83 Mn |
| Mar 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | -2.68 Mn |
| Sep 30, 2022 | -3.78 Mn |
| Jun 30, 2022 | -2.81 Mn |
| Dec 31, 2021 | -268.63 Mn |
| Sep 30, 2021 | 82,000.00 |
| Jun 30, 2021 | -561,000.00 |
| Mar 31, 2021 | -21,000.00 |
| Dec 31, 2020 | -131,000.00 |
| Sep 30, 2020 | -473,000.00 |
| Jun 30, 2020 | -46,000.00 |